| Drug Name | Lustral (Sertraline), Efexor (Venlafaxine), Pristiq (Desvenlafaxine) |
|---|---|
| Drug Class |
Anti-depressant
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Psychiatry
|
| Risk |
Warning about the Increased Risk of Postpartum Haemorrhage Associated with the Use of Lustral (Sertraline), Efexor (Venlafaxine) and Pristiq (Desvenlafaxine) in Pregnant Women |
| Dear Healthcare provider letter DHPC |
|